Formulations against cutaneous leishmaniasis
US8287921B1 · kind B1 · utility
0Cited by
0References
1Claims
0Family size
Inventors
Key dates
| Filing date | Jul 24, 2011 |
| Grant date | Oct 16, 2012 |
| Priority date | — |
| Expiry date | Jul 24, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treatment of leishmaniasis in animals and humans using the methanolic extract of Physalis minima in petrolatum is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.